• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物电阻抗光谱法用于评估维持性血液透析患者的目标体重。

Bioimpedance spectroscopy to estimate target weight in patients on maintenance haemodialysis.

作者信息

Stigger Kaiane, Ribes Kohn Eduardo, Kafer Nobre Rony, Pitol Guilherme, Feter Natan, Bohlke Maristela

机构信息

Postgraduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, Brazil.

Olomouc University Institute of Social Health, Palacký University Olomouc, Olomouc, Czech Republic.

出版信息

Cochrane Database Syst Rev. 2025 Sep 18;9(9):CD016044. doi: 10.1002/14651858.CD016044.

DOI:10.1002/14651858.CD016044
PMID:40965877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12445408/
Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of incorporating bioimpedance spectroscopy into the clinical assessment for estimating target weight in maintenance haemodialysis recipients compared with physical examination alone.

摘要

这是一项Cochrane系统评价(干预措施)的方案。目标如下:评估与单纯体格检查相比,将生物电阻抗光谱法纳入临床评估以估算维持性血液透析患者目标体重的益处和危害。

相似文献

1
Bioimpedance spectroscopy to estimate target weight in patients on maintenance haemodialysis.生物电阻抗光谱法用于评估维持性血液透析患者的目标体重。
Cochrane Database Syst Rev. 2025 Sep 18;9(9):CD016044. doi: 10.1002/14651858.CD016044.
2
BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.生物电阻抗光谱法维持肾输出量:BISTRO随机对照试验
Health Technol Assess. 2025 Jul;29(32):1-23. doi: 10.3310/RHON2378.
3
Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis: the BISTRO RCT.血液透析患者生物阻抗引导下的液体管理的成本效益:BISTRO随机对照试验
Health Technol Assess. 2024 Sep 25:1-45. doi: 10.3310/JYPR4287.
4
Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation.多频生物阻抗仪在透析慢性肾脏病患者液体管理中的应用:系统评价和经济评估。
Health Technol Assess. 2018 Jan;22(1):1-138. doi: 10.3310/hta22010.
5
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
6
Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis.生物电阻抗分析估算维持性透析患者“干体重”的价值:一项系统评价和荟萃分析。
Int Urol Nephrol. 2017 Dec;49(12):2231-2245. doi: 10.1007/s11255-017-1698-4. Epub 2017 Sep 30.
7
Home versus in-centre haemodialysis for people with kidney failure.居家透析与中心透析治疗肾衰竭患者的效果比较。
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD009535. doi: 10.1002/14651858.CD009535.pub3.
8
Low dialysate sodium levels for chronic haemodialysis.慢性血液透析中低透析液钠水平。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD011204. doi: 10.1002/14651858.CD011204.pub3.
9
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
10
UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis.英国肾脏协会血液透析血管通路临床实践指南。
BMC Nephrol. 2025 Aug 14;26(1):461. doi: 10.1186/s12882-025-04374-y.

本文引用的文献

1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
Infections and Acute Kidney Injury: A Global Perspective.感染与急性肾损伤:全球视角。
Semin Nephrol. 2023 Sep;43(5):151466. doi: 10.1016/j.semnephrol.2023.151466. Epub 2023 Dec 28.
3
Bioimpedance analysis in patients with chronic kidney disease.慢性肾病患者的生物电阻抗分析
J Ren Care. 2023 Sep;49(3):147-157. doi: 10.1111/jorc.12474.
4
Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial.生物阻抗谱分析联合液体管理方案在一项随机对照试验中并未改善新进入血液透析患者的残余肾功能保留。
Kidney Int. 2023 Sep;104(3):587-598. doi: 10.1016/j.kint.2023.05.016. Epub 2023 May 30.
5
Incidence of hospital admissions in bioimpedance-guided fluid management among maintenance hemodialysis patients-Results of a randomized controlled trial.生物阻抗指导下的液体管理在维持性血液透析患者中的住院发生率-一项随机对照试验的结果。
Hemodial Int. 2023 Jul;27(3):318-325. doi: 10.1111/hdi.13076. Epub 2023 Apr 17.
6
Standard error estimation in meta-analysis of studies reporting medians.报告中位数的研究的Meta分析中的标准误差估计。
Stat Methods Med Res. 2023 Feb;32(2):373-388. doi: 10.1177/09622802221139233. Epub 2022 Nov 22.
7
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
8
Bioimpedance analysis is not superior to clinical assessment in determining hydration status: A prospective randomized-controlled trial in a Western dialysis population.在确定水合状态方面,生物电阻抗分析并不优于临床评估:一项针对西方透析人群的前瞻性随机对照试验。
Hemodial Int. 2021 Mar 11. doi: 10.1111/hdi.12919.
9
The effect of BCM guided dry weight assessment on short-term survival in Chinese hemodialysis patients : Primary results of a randomized trial - BOdy COmposition MOnitor (BOCOMO) study.BCM 指导干体重评估对中国血液透析患者短期生存的影响:一项随机试验的主要结果 - BOdy COmposition MOnitor(BOCOMO)研究。
BMC Nephrol. 2020 Apr 15;21(1):135. doi: 10.1186/s12882-020-01793-x.
10
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.系统评价中不进行荟萃分析的综合 (SWiM):报告指南。
BMJ. 2020 Jan 16;368:l6890. doi: 10.1136/bmj.l6890.